News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Oncomatrix Signs an Agreement With the University of Stuttgart to Develop New Drugs for Treating Tumor Metastases


12/11/2012 10:47:50 AM

DERIO, Spain--(BUSINESS WIRE)--Oncomatrix, a biopharmaceutical company from the Basque country, Spain, develops personalized treatments for invasive tumors. Oncomatrix has signed an agreement with the University of Stuttgart to develop new drugs with tumor targeted activity. This partnership will allow the development of immunoconjugates able to attack the cells involved in metastasis in invasive breast and pancreas cancers.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES